Region: North America

Potential initiatives to limit continuation practice are causing deep divides in the life sciences patent community – causing technology licensors and Big Tech to take sides

07 March 2023

Highly-litigated intellectual property to feature in yet another dispute

07 March 2023

Docket Navigator data shows more patentees are filing directly in Austin – possibly to sidestep the Waco Division’s random assignment order

06 March 2023

Brian Tenner sits down with IAM to discuss the company’s win and future strategy

06 March 2023

Saturday Opinion: Disseminating covid diagnostics and therapeutics is critical, but attempting to do so via the TRIPS waiver extension is rife with unintended consequences

04 March 2023

We asked the large-language model to draft a patent claim, design around a claim, and identify prior art – and concluded that it is potentially helpful but unreliable

02 March 2023

The USPTO director shares her thoughts on life sciences IP rights and ongoing collaboration with the FDA

02 March 2023

Without significant reforms that restore the right to exclude, lower costs and clarify eligibility, SMEs will remain second class citizens and the big calls on FRAND and SEPs will be made in Europe

02 March 2023

Ron Epstein’s IP advisory firm acts as “virtual in-house counsel” for small companies and his recent successes include a $150 million settlement for one client and half-a-billion in verdicts for another

01 March 2023

Increased NPE litigation in the sector emerges from a patent buyer’s market of liquidated assets and divested obsolete portfolios

28 February 2023